+
データを開く
-
基本情報
| 登録情報 | データベース: PDB / ID: 8chf | ||||||
|---|---|---|---|---|---|---|---|
| タイトル | cryo-EM Structure of Craf:14-3-3:Mek1 | ||||||
要素 |
| ||||||
キーワード | STRUCTURAL PROTEIN / Kinase | ||||||
| 機能・相同性 | 機能・相同性情報death-inducing signaling complex assembly / epithelial cell proliferation involved in lung morphogenesis / positive regulation of endodermal cell differentiation / negative regulation of homotypic cell-cell adhesion / negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway / regulation of vascular associated smooth muscle contraction / intermediate filament cytoskeleton organization / regulation of axon regeneration / mitogen-activated protein kinase kinase / positive regulation of muscle contraction ...death-inducing signaling complex assembly / epithelial cell proliferation involved in lung morphogenesis / positive regulation of endodermal cell differentiation / negative regulation of homotypic cell-cell adhesion / negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway / regulation of vascular associated smooth muscle contraction / intermediate filament cytoskeleton organization / regulation of axon regeneration / mitogen-activated protein kinase kinase / positive regulation of muscle contraction / Golgi inheritance / placenta blood vessel development / MAP-kinase scaffold activity / cerebellar cortex formation / labyrinthine layer development / regulation of Rho protein signal transduction / melanosome transport / type B pancreatic cell proliferation / Signaling by MAP2K mutants / SHOC2 M1731 mutant abolishes MRAS complex function / Gain-of-function MRAS complexes activate RAF signaling / Rap1 signalling / vesicle transport along microtubule / positive regulation of Ras protein signal transduction / insulin secretion involved in cellular response to glucose stimulus / regulation of Golgi inheritance / central nervous system neuron differentiation / mitogen-activated protein kinase kinase kinase binding / positive regulation of axonogenesis / trachea formation / triglyceride homeostasis / Negative feedback regulation of MAPK pathway / regulation of early endosome to late endosome transport / IFNG signaling activates MAPKs / regulation of stress-activated MAPK cascade / Frs2-mediated activation / GP1b-IX-V activation signalling / MAPK3 (ERK1) activation / ERBB2-ERBB3 signaling pathway / neurotrophin TRK receptor signaling pathway / regulation of neurotransmitter receptor localization to postsynaptic specialization membrane / face development / endodermal cell differentiation / pseudopodium / MAP kinase kinase activity / Bergmann glial cell differentiation / regulation of cell differentiation / positive regulation of ATP biosynthetic process / thyroid gland development / Uptake and function of anthrax toxins / positive regulation of protein serine/threonine kinase activity / extrinsic apoptotic signaling pathway via death domain receptors / somatic stem cell population maintenance / positive regulation of peptidyl-serine phosphorylation / MAP kinase kinase kinase activity / protein kinase activator activity / type II interferon-mediated signaling pathway / Schwann cell development / response to axon injury / negative regulation of extrinsic apoptotic signaling pathway via death domain receptors / negative regulation of protein-containing complex assembly / keratinocyte differentiation / neuron projection morphogenesis / response to muscle stretch / ERK1 and ERK2 cascade / myelination / positive regulation of autophagy / protein serine/threonine/tyrosine kinase activity / CD209 (DC-SIGN) signaling / insulin-like growth factor receptor signaling pathway / dendrite cytoplasm / response to glucocorticoid / thymus development / adenylate cyclase activator activity / MAP3K8 (TPL2)-dependent MAPK1/3 activation / protein serine/threonine kinase activator activity / Signal transduction by L1 / cell motility / wound healing / positive regulation of transcription elongation by RNA polymerase II / RAF activation / Signaling by high-kinase activity BRAF mutants / MAP2K and MAPK activation / small GTPase binding / Stimuli-sensing channels / chemotaxis / neuron differentiation / Negative regulation of MAPK pathway / Signaling by RAF1 mutants / Signaling by moderate kinase activity BRAF mutants / Paradoxical activation of RAF signaling by kinase inactive BRAF / Signaling downstream of RAS mutants / cellular senescence / Signaling by BRAF and RAF1 fusions / insulin receptor signaling pathway / late endosome / MAPK cascade / heart development / response to oxidative stress / protein tyrosine kinase activity 類似検索 - 分子機能 | ||||||
| 生物種 | Homo sapiens (ヒト)![]() | ||||||
| 手法 | 電子顕微鏡法 / 単粒子再構成法 / クライオ電子顕微鏡法 / 解像度: 4.25 Å | ||||||
データ登録者 | Dedden, D. / Ulrich, G. | ||||||
| 資金援助 | ドイツ, 1件
| ||||||
引用 | ジャーナル: J Mol Biol / 年: 2024タイトル: Cryo-EM Structures of CRAF/14-3-3 and CRAF/14-3-3/MEK1 Complexes. 著者: Dirk Dedden / Julius Nitsche / Elisabeth V Schneider / Maren Thomsen / Daniel Schwarz / Birgitta Leuthner / Ulrich Grädler / ![]() 要旨: RAF protein kinases are essential effectors in the MAPK pathway and are important cancer drug targets. Structural understanding of RAF activation is so far based on cryo-electron microscopy (cryo-EM) ...RAF protein kinases are essential effectors in the MAPK pathway and are important cancer drug targets. Structural understanding of RAF activation is so far based on cryo-electron microscopy (cryo-EM) and X-ray structures of BRAF in different conformational states as inactive or active complexes with KRAS, 14-3-3 and MEK1. In this study, we have solved the first cryo-EM structures of CRAF/14-3-3 at 3.4 Å resolution and CRAF/14-3-3/MEK1 at 4.2 Å resolution using CRAF kinase domain expressed as constitutively active Y340D/Y341D mutant in insect cells. The overall architecture of our CRAF/14-3-3 and CRAF/14-3-3/MEK1 cryo-EM structures is highly similar to corresponding BRAF structures in complex with 14-3-3 or 14-3-3/MEK1 and represent the activated dimeric RAF conformation. Our CRAF cryo-EM structures provide additional insights into structural understanding of the activated CRAF/14-3-3/MEK1 complex. | ||||||
| 履歴 |
|
-
構造の表示
| 構造ビューア | 分子: Molmil Jmol/JSmol |
|---|
-
ダウンロードとリンク
-
ダウンロード
| PDBx/mmCIF形式 | 8chf.cif.gz | 299.8 KB | 表示 | PDBx/mmCIF形式 |
|---|---|---|---|---|
| PDB形式 | pdb8chf.ent.gz | 233.7 KB | 表示 | PDB形式 |
| PDBx/mmJSON形式 | 8chf.json.gz | ツリー表示 | PDBx/mmJSON形式 | |
| その他 | その他のダウンロード |
-検証レポート
| アーカイブディレクトリ | https://data.pdbj.org/pub/pdb/validation_reports/ch/8chf ftp://data.pdbj.org/pub/pdb/validation_reports/ch/8chf | HTTPS FTP |
|---|
-関連構造データ
| 関連構造データ | ![]() 16660MC ![]() 8cpdC M: このデータのモデリングに利用したマップデータ C: 同じ文献を引用 ( |
|---|---|
| 類似構造データ | 類似検索 - 機能・相同性 F&H 検索 |
-
リンク
-
集合体
| 登録構造単位 | ![]()
|
|---|---|
| 1 |
|
-
要素
| #1: タンパク質 | 分子量: 73184.477 Da / 分子数: 2 / 由来タイプ: 組換発現 / 由来: (組換発現) Homo sapiens (ヒト) / 遺伝子: RAF1, RAF発現宿主: ![]() 参照: UniProt: P04049, non-specific serine/threonine protein kinase #2: タンパク質 | 分子量: 28108.514 Da / 分子数: 2 / 由来タイプ: 天然 由来: (天然) ![]() 参照: UniProt: A0A9R0D7T1 #3: タンパク質 | 分子量: 43461.938 Da / 分子数: 2 / 由来タイプ: 組換発現 / 由来: (組換発現) Homo sapiens (ヒト) / 遺伝子: MAP2K1, MEK1, PRKMK1発現宿主: ![]() 参照: UniProt: Q02750, mitogen-activated protein kinase kinase #4: 化合物 | 研究の焦点であるリガンドがあるか | Y | Has protein modification | Y | |
|---|
-実験情報
-実験
| 実験 | 手法: 電子顕微鏡法 |
|---|---|
| EM実験 | 試料の集合状態: PARTICLE / 3次元再構成法: 単粒子再構成法 |
-
試料調製
| 構成要素 | 名称: Complex of dimer phosphorylated C-raf kinase domain with 14-3-3 dimer and 2 subunits of Mek1 containing ligand GDC-0623 タイプ: COMPLEX / Entity ID: #1-#3 / 由来: MULTIPLE SOURCES |
|---|---|
| 由来(天然) | 生物種: Homo sapiens (ヒト) |
| 由来(組換発現) | 生物種: ![]() |
| 緩衝液 | pH: 7.5 |
| 試料 | 濃度: 0.4 mg/ml / 包埋: NO / シャドウイング: NO / 染色: NO / 凍結: YES |
| 試料支持 | グリッドの材料: COPPER / グリッドのサイズ: 300 divisions/in. / グリッドのタイプ: Quantifoil R1.2/1.3 |
| 急速凍結 | 装置: FEI VITROBOT MARK IV / 凍結剤: ETHANE-PROPANE / 湿度: 100 % / 凍結前の試料温度: 298 K |
-
電子顕微鏡撮影
| 顕微鏡 | モデル: TFS GLACIOS |
|---|---|
| 電子銃 | 電子線源: FIELD EMISSION GUN / 加速電圧: 200 kV / 照射モード: FLOOD BEAM |
| 電子レンズ | モード: BRIGHT FIELD / 倍率(公称値): 150000 X / 最大 デフォーカス(公称値): 2300 nm / 最小 デフォーカス(公称値): 700 nm / Cs: 2.7 mm / C2レンズ絞り径: 50 µm |
| 試料ホルダ | 凍結剤: NITROGEN 試料ホルダーモデル: FEI TITAN KRIOS AUTOGRID HOLDER |
| 撮影 | 平均露光時間: 7 sec. / 電子線照射量: 60 e/Å2 フィルム・検出器のモデル: FEI FALCON IV (4k x 4k) 撮影したグリッド数: 1 / 実像数: 2732 |
| 画像スキャン | サンプリングサイズ: 0.9142 µm / 横: 4096 / 縦: 4096 |
-
解析
| CTF補正 | タイプ: PHASE FLIPPING AND AMPLITUDE CORRECTION | ||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3次元再構成 | 解像度: 4.25 Å / 解像度の算出法: FSC 0.143 CUT-OFF / 粒子像の数: 79383 / アルゴリズム: FOURIER SPACE / 対称性のタイプ: POINT | ||||||||||||||||||||||||
| 原子モデル構築 | プロトコル: RIGID BODY FIT | ||||||||||||||||||||||||
| 精密化 | 解像度: 4.25→4.25 Å / Cor.coef. Fo:Fc: 0.931 / SU B: 70.636 / SU ML: 0.767 / ESU R: 0.375 立体化学のターゲット値: MAXIMUM LIKELIHOOD WITH PHASES 詳細: HYDROGENS HAVE BEEN ADDED IN THE RIDING POSITIONS
| ||||||||||||||||||||||||
| 溶媒の処理 | 溶媒モデル: PARAMETERS FOR MASK CACLULATION | ||||||||||||||||||||||||
| 原子変位パラメータ | Biso mean: 161.235 Å2 | ||||||||||||||||||||||||
| 精密化ステップ | サイクル: 1 / 合計: 12526 | ||||||||||||||||||||||||
| 拘束条件 |
| ||||||||||||||||||||||||
| LS精密化 シェル | 解像度: 4.2→4.309 Å / Total num. of bins used: 20
|
ムービー
コントローラー
万見について




Homo sapiens (ヒト)

ドイツ, 1件
引用


PDBj











gel filtration
